Thus, IL-17-producing Treg may act as a double-edged sword, by both promoting tumor growth and reducing protective Th1-type responses, and this may be particularly relevant in intestinal tumors in close contact with the intestinal flora [34, 50]. The gene discussed is IL17A; the disease is neoplasm.